Saturday, August 9, 2025

Pure Extracts Scales Up THC, CBD Distillate Production

Pure Extracts (CSE: PULL) is looking to scale up its production of both THC and CBD extracts. The company this morning announced that it has entered into two of its first substantial biomass purchase agreements to support the scale-up.

The biomass purchases by the company are for both THC and CBD varieties. For THC, the company has secured 200 kilograms of high potency dried cannabis flower from a large licensed producer. For CBD, the company has agreed to purchase 1,000 kilograms of high potency biomass from a western producer.

The decision to begin the ramp up of operations follows the falling of biomass prices after the fall outdoor harvest. The purchases are expected to drive revenue growth within Q1 2021.

Once extracted, it is expected that the company will be able to produce approximately 70 kilograms of CBD distillate, as well as 25 kilograms of THC distillate from the biomass. At current market prices, the firm expects the distillate to lead to up to $590,000 in near term sales revenue.

“Having a stockpile of biomass makes sense for us now as Pure Extracts starts to build its name in the elite category of extractors. We are looking forward to showcasing our world class products and consistently ramping-up revenue this year.”

Ben Nikolaevsky, CEO of Pure Extracts

Pure Extracts last traded at $0.70 on the CSE.


FULL DISCLOSURE: Pure Extracts is a client of Canacom Group, the parent company of The Deep Dive. The author has been compensated to cover Pure Extracts on The Deep Dive, with The Deep Dive having full editorial control. Not a recommendation to buy or sell. Always do additional research and consult a professional before purchasing a security.

Video Articles

Gold/Silver: People Can Still Lose Money In This Bull Market!? | Rick Rule

He Said $300 Silver!? | Peter Krauth

Dollar Will Collapse, Gold and Silver Are the Only Safe Havens | Jim Rogers

Recommended

Nova Scotia Bans Forest Access to Prevent Wildfires

Cardiol Therapeutics Releases Positive Topline Results From Phase II Clinical Trial

Related News

Pure Extracts Submits Application For First Natural Product Number

Pure Extracts (CSE: PULL) is one step closer to commercializing its functional mushroom operation. The...

Wednesday, February 3, 2021, 07:03:35 AM

Pure Extracts Raises $8.5 Million In Upsized Special Warrant Financing

Pure Extracts (CSE: PULL) yesterday announced the closure of its offering of special warrants, raising...

Friday, January 22, 2021, 11:03:00 AM

Pure Extracts Sees First Commercial Sale Of CBD Oil

Pure Extracts (CSE: PULL) has completed its first commercial sale of CBD oil, and thereby...

Wednesday, February 10, 2021, 07:11:33 AM

Pure Extracts Outlines Psilocybin Study Timeline

Further details were released by Pure Extracts (CSE: PULL) this morning in relation to its...

Thursday, January 14, 2021, 07:24:18 AM

The Deep Dive Compiles Company Profile On Pure Extracts

Pure Extracts (CSE: PULL, tentatively) is positioned for growth in the commercial cannabis and functional mushroom...

Sunday, October 18, 2020, 10:49:00 AM